Document Detail

Characteristics and In-Hospital Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing an Invasive Strategy According to Hemoglobin Levels.
MedLine Citation:
PMID:  23453458     Owner:  NLM     Status:  Publisher    
The benefit of an invasive strategy in non-ST-segment elevation myocardial infarction (NSTEMI) was established from randomized trials that included few anemic patients. The aim of this study was to describe the characteristics, therapies, and mortality of patients with NSTEMIs who undergo an invasive strategy in relation to their admission hemoglobin levels. Data from 73,067 patients with NSTEMIs who underwent cardiac catheterization and who were captured by the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines (ACTION-GWTG) were examined. Patients were divided into 3 hemoglobin groups on the basis of initial hemoglobin level: (1) <10 g/dl, (2) 10 to 12 g/dl, or (3) >12 g/dl. Patients with hemoglobin <10 g/dl had more co-morbidities and more 3-vessel coronary artery disease at catheterization compared with those with hemoglobin >12 g/dl (46.2% vs 33.9%, all p values <0.0001). They received fewer acute antithrombotic therapies, less often underwent revascularization (57.4% vs 74.1%), and had higher rates of red blood cell transfusion before catheterization (32.1% vs 0.3%, all p values <0.0001). After adjustment, in-hospital mortality was inversely associated with initial hemoglobin, with a 7% increase for each 1 g/dl decrease in hemoglobin lower than 15 g/dl (odds ratio 1.07, 95% confidence interval 1.02 to 1.11). In conclusion, in patients presenting with NSTEMIs and managed with an invasive strategy, a lower hemoglobin level is associated with more extensive coronary artery disease, less use of revascularization and evidence-based therapies, and increased mortality.
Elias B Hanna; Karen P Alexander; Anita Y Chen; Matthew T Roe; Marjorie Funk; Jorge F Saucedo
Related Documents :
25097568 - Comparing mortality and myocardial infarction between coronary artery bypass grafting a...
24419808 - Bioresorbable vascular scaffolds in acute st-segment elevation myocardial infarction: a...
23973038 - Pros, cons, and organization of prehospital thrombolysis.
23271458 - Improvement of left ventricular longitudinal systolic function after transcatheter aort...
19060498 - Gemcitabine-induced acute coronary syndrome: a case report.
9925968 - N-acetylheparin pretreatment reduces infarct size in the rabbit.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-27
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-3-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Cardiovascular Section, Louisiana State University, New Orleans, Lousiana. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Usefulness of Electrocardiographic Frontal QRS-T Angle to Predict Increased Morbidity and Mortality ...
Next Document:  Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure afte...